ANROVSLABT• 28 Days (Normalized)
ANRO vs LABT (Alto Neuroscience Inc. vs Lakewood-Amedex Biotherapeutics Inc.)
Showing Closing Date Range from Sep 2 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ANRO Performance $27.5
+%
Alto Neuroscience Inc.
Normalized Baseline0.00%
LABT Performance $0.99
-52.17%
Lakewood-Amedex Biotherapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin ANRO LEADS
+52.17 pts
ANRO outperforming by 52.17 percentage points
ANROLABT
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ANRO LABT
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(19 dates)
| Date | ANRO Price | ANRO Gain (%) | LABT Price | LABT Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $- | $0.99 | -52.17% | - | |
| Sep 28, 2026 | $- | $1.15 | -44.44% | - | |
| Sep 25, 2026 | $- | $1.67 | -19.32% | - | |
| Sep 24, 2026 | $- | $1.83 | -11.59% | - | |
| Sep 23, 2026 | $27.50 | -24.95% | $1.78 | -14.01% | -10.94% |
| Sep 22, 2026 | $30.78 | -15.99% | $1.99 | -3.86% | -12.13% |
| Sep 21, 2026 | $30.63 | -16.40% | $2.05 | -0.97% | -15.43% |
| Sep 18, 2026 | $30.27 | -17.39% | $1.99 | -3.86% | -13.53% |
| Sep 17, 2026 | $30.98 | -15.45% | $1.86 | -10.14% | -5.31% |
| Sep 16, 2026 | $30.00 | -18.12% | $2.09 | +0.97% | -19.09% |
| Sep 15, 2026 | $30.25 | -17.44% | $2.17 | +4.83% | -22.27% |
| Sep 14, 2026 | $31.68 | -13.54% | $2.12 | +2.42% | -15.96% |
| Sep 11, 2026 | $32.00 | -12.66% | $2.22 | +7.25% | -19.91% |
| Sep 10, 2026 | $31.68 | -13.54% | $2.05 | -0.97% | -12.57% |
| Sep 09, 2026 | $34.07 | -7.01% | $2.32 | +12.08% | -19.09% |
Page 1 of 2